Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R antagonist

Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R antagonist

US Patent 11504426 · Granted Nov 22, 2022

Estimated economic value: $100,000,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for treating atopic dermatitis by administering an IL-4R antagonist2025
Methods for treating atopic dermatitis by administering an IL-4R antagonist2025
Methods for treating or preventing asthma by administering an IL-4R antagonist2025
Methods for reducing eosinophilic infiltration by administering an anti-interleu2025
Methods for treating or preventing SARS-CoV-2 infections and COVID-19 with anti-2024
Methods for treating or preventing SARS-CoV-2 infections and COVID-19 with anti-2024
Methods of treating allergy using anti-Bet v 1 antibodies2024
Methods for treating or preventing asthma by administering an IL-4R antagonist2023
Methods for treating or preventing asthma by administering an IL-4R antagonist2023
Methods for preventing or treating allergy by administering an IL-4R antagonist2023
Methods for treating skin infection by administering an IL-4R antagonist2023
Methods for treating skin infection by administering an IL-4R antagonist2023